EREmilie F. Rissman

Emilie F. Rissman

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Emilie F. Rissman has a total of 94 co-authors. Here are the top co-authors by number of shared publications:

  • Erin P. Harris

    Center for Human Health and the Environment, North Carolina State University, Raleigh, NC 27695, USA

    6 shared publications
  • Mariangela Martini

    Center for Human Health and the Environment Program in Genetics, North Carolina State University, Raleigh, NC USA

    4 shared publications
  • Kayla M. Quinnies

    Neuroscience Graduate Program and Department of Biochemistry and Molecular Genetics (K.M.Q., E.F.R.), University of Virginia School of Medicine, Charlottesville, Virginia 22903; and School of Molecular Biosciences (T.J.D., K.H.K.), College of Veterinary Medicine, Washington State University, Pullman, Washington 99164

    3 shared publications
  • Wendy J. Lynch

    Department of Psychiatry and Neurobehavioral Sciences University of Virginia School of Medicine 22903 Charlottesville VA

    3 shared publications
  • Anne D Henriksen

    Department of Integrated Science and Technology, James Madison University, Harrisonburg, Virginia

    2 shared publications
  • Jennifer T Wolstenholme

    Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, Virginia

    2 shared publications

Latest Publications

  • Open Access

    Role of Hormones in Substance Use Disorders

    by Emilie F. Rissman, Wendy J. Lynch


  • Sex Chromosome Complement and Estradiol Modify Cocaine Self-Administration Behaviors in Male Mice

    by Aaron L. Le, Wendy J. Lynch, Emilie F. Rissman

    Introduction: Women are more vulnerable to cocaine’s reinforcing effects and have a more rapid course to addiction after initial cocaine use as compared to men. Studies in rodents similarly indicate an enhanced sensitivity to the reinforcing effects of cocaine in females versus males. Levels of estradiol (E2) are correlated with vulnerability to the rewarding actions of cocaine. Here, we asked if sex chromosome complement (SCC) influences vulnerability to cocaine use. Methods: We used the four-core genotype mouse that produces gonadal males and females with either XX or XY SCC. Mice were gonadectomized and implanted with either an estradiol (E2) or cholesterol-filled pellet. This allowed us to determine the effects of SCC in the absence (cholesterol-treated) and presence of tonic high physiological hormone levels (estradiol). Acquisition of cocaine self-administration was determined over a 12-day period using an escalated dose procedure (0.3 mg/kg/infusion, sessions 1–6; 0.6 mg/kg/infusion, sessions 6–12). Results: Without estradiol treatment, a greater percentage of castrated XY mice acquired cocaine self-administration and did so at a faster rate than XX castrates and ovariectomized XY females. These same XY males acquired sooner, infused more cocaine, and directed more nose pokes to the rewarded nose-poke hole than XX castrates and XY males receiving E2. Conclusion: Our results suggest that in gonadal male mice, SCC and estradiol can modulate the reinforcing effects of cocaine which may influence the likelihood of cocaine use.


  • Fentanyl-induced acute and conditioned behaviors in two inbred mouse lines: Potential role for Glyoxalase

    by Samuel J. Harp, Mariangela Martini, Will Rosenow, Larry D. Mesner, Hugh Johnson, Charles R. Farber, Emilie F. Rissman


  • Open Access

    Beyond Genes: Germline Disruption in the Etiology of Autism Spectrum Disorders

    by Jill Escher, Wei Yan, Emilie F. Rissman, Hsiao-Lin V. Wang, Arturo Hernandez, Victor G. Corces

    Investigations into the etiology of autism spectrum disorders have been largely confined to two realms: variations in DNA sequence and somatic developmental exposures. Here we suggest a third route—disruption of the germline epigenome induced by exogenous toxicants during a parent’s gamete development. Similar to cases of germline mutation, these molecular perturbations may produce dysregulated transcription of brain-related genes during fetal and early development, resulting in abnormal neurobehavioral phenotypes in offspring. Many types of exposures may have these impacts, and here we discuss examples of anesthetic gases, tobacco components, synthetic steroids, and valproic acid. Alterations in parental germline could help explain some unsolved phenomena of autism, including increased prevalence, missing heritability, skewed sex ratio, and heterogeneity of neurobiology and behavior.


  • Sex chromosome complement influences vulnerability to cocaine in mice

    by Mariangela Martini, Joshua W. Irvin, Christina G. Lee, Wendy J. Lynch, Emilie F. Rissman


  • Open Access

    Sexual Differentiation and Substance Use: A Mini-Review

    by Samuel J Harp, Mariangela Martini, Wendy J Lynch, Emilie F Rissman

    The organizational/activational hypothesis suggests that gonadal steroid hormones like testosterone (T) and estradiol (E2) are important at 2 different times during the lifespan when they perform 2 different functions. First steroids “organize” brain structures early in life and during puberty, and in adults these same hormones “activate” sexually dimorphic behaviors. This hypothesis has been tested and proven valid for a large number of behaviors (learning, memory, social, and sexual behaviors). Sex differences in drug addiction are well established both for humans and animal models. Previous research in this field has focused primarily on cocaine self-administration by rats. Traditionally, observed sex differences have been explained by the sex-specific concentrations of gonadal hormones present at the time of the drug-related behavior. Studies with gonadectomized rodents establishes an activational role for E2 that facilitates vulnerability in females, and when E2 is combined with progesterone, addiction is attenuated. Literature on organizational actions of steroids is sparse but predicts that T, after it is aromatized to E2, changes aspects of the neural reward system. Here we summarize these data and propose that sex chromosome complement also plays a role in determining sex-specific drug-taking behavior. Future research is needed to disentangle the effects of hormones and sex chromosome complement, and we propose the four core genotype mouse model as an effective tool for answering these questions.


  • Open Access

    Bisphenol A Exposure in utero Disrupts Hypothalamic Gene Expression Particularly Genes Suspected in Autism Spectrum Disorders and Neuron and Hormone Signaling

    by Anne D. Henriksen, Alejandro Andrade, Erin P. Harris, Emilie F. Rissman, Jennifer T. Wolstenholme

    Bisphenol A (BPA) is an endocrine-disrupting compound detected in the urine of more than 92% of humans, easily crosses the placental barrier, and has been shown to influence gene expression during fetal brain development. The purpose of this study was to investigate the effect of in utero BPA exposure on gene expression in the anterior hypothalamus, the basal nucleus of the stria terminalis (BNST), and hippocampus in C57BL/6 mice. Mice were exposed in utero to human-relevant doses of BPA, and then RNA sequencing was performed on male PND 28 tissue from whole hypothalamus (n = 3/group) that included the medial preoptic area (mPOA) and BNST to determine whether any genes were differentially expressed between BPA-exposed and control mice. A subset of genes was selected for further study using RT-qPCR on adult tissue from hippocampus to determine whether any differentially expressed genes (DEGs) persisted into adulthood. Two different RNA-Seq workflows indicated a total of 259 genes that were differentially expressed between BPA-exposed and control mice. Gene ontology analysis indicated that those DEGs were overrepresented in categories relating to mating, cell–cell signaling, behavior, neurodevelopment, neurogenesis, synapse formation, cognition, learning behaviors, hormone activity, and signaling receptor activity, among others. Ingenuity Pathway Analysis was used to interrogate novel gene networks and upstream regulators, indicating the top five upstream regulators as huntingtin, beta-estradiol, alpha-synuclein, Creb1, and estrogen receptor (ER)-alpha. In addition, 15 DE genes were identified that are suspected in autism spectrum disorders.


  • Transgenerational Bisphenol A Causes Deficits in Social Recognition and Alters Postsynaptic Density Genes in Mice

    by Jennifer T Wolstenholme, Zuzana Drobná, Anne D Henriksen, Jessica A Goldsby, Rachel Stevenson, Joshua W Irvin, Jodi A Flaws, Emilie F Rissman

    Bisphenol A (BPA) is a ubiquitous endocrine-disrupting chemical. Developmental exposure produces changes in behavior and gene expression in the brain. Here, we examined social recognition behaviors in mice from the third familial generation (F3) after exposure to gestational BPA. Second-generation mice were bred in one of four mating combinations to reveal whether characteristics in F3 were acquired via maternal or paternal exposures. After repeated habituation to the same mouse, offspring of dams from the BPA lineage failed to display increased investigation of a novel mouse. Genes involved in excitatory postsynaptic densities (PSDs) were examined in F3 brains using quantitative PCR. Differential expression of genes important for function and stability of PSDs were assessed at three developmental ages. Several related PSD genes―SH3 and multiple ankyrin repeat domains 1 (Shank1), Homer scaffolding protein 1c (Homer1c), DLG associated protein 1 (Gkap), and discs large MAGUK scaffold protein 4 (PSD95)―were differentially expressed in control- vs BPA-lineage brains. Using a second strain of F3 inbred mice exposed to BPA, we noted the same differences in Shank1 and PSD95 expression in C57BL/6J mice. In sum, transgenerational BPA exposure disrupted social interactions in mice and dysregulated normal expression of PSD genes during neural development. The fact that the same genetic effects were found in two different mouse strains and in several brain regions increased potential for translation. The genetic and functional relationship between PSD and abnormal neurobehavioral disorders is well established, and our data suggest that BPA may contribute in a transgenerational manner to neurodevelopmental diseases.


  • Bisphenol F has different effects on preadipocytes differentiation and weight gain in adult mice as compared with Bisphenol A and S

    by Zuzana Drobna, Alzbeta Talarovicova, Hannah E. Schrader, Timothy R. Fennell, Rodney W. Snyder, Emilie F. Rissman